Cellectar Biosciences, Inc. Restructuring Costs
Cellectar Biosciences, Inc. (CLRB) reported Restructuring Costs of $1.51 million for the 1-month period ending 2024-12-31, per its 10-K filed 2026-03-04.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestructuringCosts · last filed 2026-03-04
- Cellectar Biosciences, Inc. restructuring costs for the quarter ending 2016-12-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. restructuring costs for the quarter ending 2016-09-30 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. restructuring costs for the quarter ending 2016-06-30 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. restructuring costs for the quarter ending 2016-03-31 was $0.00.
- Cellectar Biosciences, Inc. restructuring costs for fiscal 2016 was $0.00, a 100.00% decline from fiscal 2015.
- Cellectar Biosciences, Inc. restructuring costs for fiscal 2015 was $203.63K, a 8.20% decline from fiscal 2014.
- Cellectar Biosciences, Inc. restructuring costs for fiscal 2014 was $221.82K, a 79.78% decline from fiscal 2013.
- Cellectar Biosciences, Inc. restructuring costs for fiscal 2013 was $1.10M.
| Period end | Restructuring Costs 1 month | Restructuring Costs 3 month | Restructuring Costs 6 month | Restructuring Costs 9 month | Restructuring Costs 12 month | Restructuring Costs 134 month | Restructuring Costs 137 month |
|---|---|---|---|---|---|---|---|
| 2024-12-31 | $1.51M 10-K · filed 2026-03-04 | ||||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 derived: sum of 3 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||
| 2016-09-30 | $0.00 10-Q · filed 2016-11-10 | $0.00 derived: sum of 2 quarters · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | $23.28K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2016-06-30 | $0.00 10-Q · filed 2016-08-11 | $0.00 10-Q · filed 2016-08-11 | $23.28K derived: sum of 3 quarters · filed 2017-03-15 | $113.13K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2016-03-31 | $0.00 derived: 10-K 12 month − 3 quarters · filed 2017-03-15 | $23.28K derived: sum of 2 quarters · filed 2017-03-15 | $113.13K derived: sum of 3 quarters · filed 2017-03-15 | $203.63K derived: sum of 4 quarters · filed 2017-03-15 | |||
| 2015-12-31 | $23.28K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $113.13K derived: sum of 2 quarters · filed 2017-03-15 | $203.63K derived: sum of 3 quarters · filed 2017-03-15 | $203.63K 10-K · filed 2017-03-15 | |||
| 2015-09-30 | $89.85K 10-Q · filed 2016-11-10 | $180.35K derived: sum of 2 quarters · filed 2016-11-10 | $180.35K 10-Q · filed 2016-11-10 | $180.35K derived: sum of 4 quarters · filed 2016-11-10 | |||
| 2015-06-30 | $90.50K 10-Q · filed 2016-08-11 | $90.50K 10-Q · filed 2016-08-11 | $90.50K derived: sum of 3 quarters · filed 2016-10-20 | $90.50K derived: sum of 4 quarters · filed 2016-10-20 | |||
| 2015-03-31 | $0.00 10-Q · filed 2015-05-20 | $1.00 derived: sum of 2 quarters · filed 2016-10-20 | $1.00 derived: sum of 3 quarters · filed 2016-10-20 | $204.94K derived: sum of 4 quarters · filed 2016-10-20 | |||
| 2014-12-31 | $1.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-10-20 | $1.00 derived: sum of 2 quarters · filed 2016-10-20 | $204.94K derived: sum of 3 quarters · filed 2016-10-20 | $221.82K 10-K/A · filed 2016-10-20 | |||
| 2014-09-30 | $0.00 10-Q · filed 2015-11-12 | $204.93K derived: sum of 2 quarters · filed 2015-11-12 | $221.81K 10-Q · filed 2015-11-12 | $1.32M derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | $204.93K 10-Q · filed 2015-08-12 | $221.81K 10-Q · filed 2015-08-12 | $1.32M derived: sum of 3 quarters · filed 2015-08-12 | $1.32M derived: sum of 4 quarters · filed 2015-08-12 | |||
| 2014-03-31 | $16.88K 10-Q · filed 2015-05-20 | $1.11M derived: sum of 2 quarters · filed 2015-05-20 | $1.11M derived: sum of 3 quarters · filed 2015-05-20 | $1.11M derived: sum of 4 quarters · filed 2015-05-20 | $1.11M 10-Q · filed 2014-05-14 | ||
| 2013-12-31 | $1.10M derived: 10-K 12 month − 10-Q 9 month · filed 2015-05-20 | $1.10M derived: sum of 2 quarters · filed 2015-05-20 | $1.10M derived: sum of 3 quarters · filed 2015-05-20 | $1.10M 10-K · filed 2015-05-20 | $1.10M 10-K · filed 2014-03-19 | ||
| 2013-09-30 | $0.00 10-Q · filed 2015-05-20 | $0.00 derived: sum of 2 quarters · filed 2015-05-20 | $0.00 10-Q · filed 2015-05-20 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-08-04 | $0.00 10-Q · filed 2014-08-04 | |||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | ||||||
| 2012-12-31 | $0.00 10-K · filed 2014-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |